German DRG lump sums cover all but nonresponders in AML

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.609, 2010-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substantial costs for stem cell transplantation in AML, ALL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 385, 2002-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Poly (D,L-lactic-co-glycolide) Nanoparticles for the Improved Therapeutic Efficacy of All-trans-retinoic Acid: A Study of Acute Myeloid Leukemia (AML) Cell Differentiation In Vitro

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-01 ,pp. : 805-810

Bentham Science Publishers

Access to resources Recommend Favorite

NCCN updates guidelines for AML

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Polo-like kinases in AML

By Berg Tobias Bug Gesine Ottmann Oliver G Strebhardt Klaus

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1069-1074

Informa Healthcare

Access to resources Recommend Favorite

Midostaurin shows activity in AML

Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite